Drug Type Cell therapy |
Synonyms TBP 301, TBP-301 |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Phase 1 | United States | 30 Jan 2022 | |
Opioid-Related Disorders | Preclinical | United States | - |